Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126716101 | 12671610 | 1 | I | 20160731 | 20160809 | 20160822 | 20160822 | EXP | GB-MHRA-EYC 00143339 | GB-TEVA-684721ACC | TEVA | 83.00 | YR | M | Y | 0.00000 | 20160822 | MD | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126716101 | 12671610 | 1 | PS | AMIODARONE | AMIODARONE | 1 | Oral | 100 MILLIGRAM DAILY; | U | 74739 | 100 | MG | QD | ||||||
| 126716101 | 12671610 | 2 | C | ACLIDINIUM | ACLIDINIUM BROMIDE | 1 | 0 | ||||||||||||
| 126716101 | 12671610 | 3 | C | BUMETANIDE. | BUMETANIDE | 1 | 0 | ||||||||||||
| 126716101 | 12671610 | 4 | C | FINASTERIDE. | FINASTERIDE | 1 | 0 | ||||||||||||
| 126716101 | 12671610 | 5 | C | FLUCLOXACILLIN | FLUCLOXACILLIN | 1 | 0 | ||||||||||||
| 126716101 | 12671610 | 6 | C | GLICLAZIDE | GLICLAZIDE | 1 | 0 | ||||||||||||
| 126716101 | 12671610 | 7 | C | LAXIDO | POLYETHYLENE GLYCOL 3350POTASSIUM CHLORIDESODIUM BICARBONATESODIUM CHLORIDE | 1 | 0 | ||||||||||||
| 126716101 | 12671610 | 8 | C | METOLAZONE. | METOLAZONE | 1 | 0 | ||||||||||||
| 126716101 | 12671610 | 9 | C | SAXAGLIPTIN | SAXAGLIPTIN | 1 | 0 | ||||||||||||
| 126716101 | 12671610 | 10 | C | SENNA | SENNA LEAFSENNOSIDESSENNOSIDES A AND B | 1 | 0 | ||||||||||||
| 126716101 | 12671610 | 11 | C | WARFARIN | WARFARIN | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126716101 | 12671610 | 1 | Atrial fibrillation |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126716101 | 12671610 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126716101 | 12671610 | Cellulitis | |
| 126716101 | 12671610 | Dehydration | |
| 126716101 | 12671610 | Electrocardiogram QT prolonged | |
| 126716101 | 12671610 | Electrocardiogram U-wave abnormality | |
| 126716101 | 12671610 | General physical health deterioration | |
| 126716101 | 12671610 | Renal injury |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126716101 | 12671610 | 1 | 20160731 | 0 | ||
| 126716101 | 12671610 | 5 | 20160724 | 0 |